82 related articles for article (PubMed ID: 8708755)
1. In vivo quantification of human pulmonary beta-adrenoceptor density using PET: comparison with in vitro radioligand binding.
Qing F; Rhodes CG; Hayes MJ; Krausz T; Fountain SW; Jones T; Hughes JM
J Nucl Med; 1996 Aug; 37(8):1275-81. PubMed ID: 8708755
[TBL] [Abstract][Full Text] [Related]
2. In vivo quantification of pulmonary beta-adrenoceptor density in humans with (S)-[11C]CGP-12177 and PET.
Ueki J; Rhodes CG; Hughes JM; De Silva R; Lefroy DC; Ind PW; Qing F; Brady F; Luthra SK; Steel CJ
J Appl Physiol (1985); 1993 Aug; 75(2):559-65. PubMed ID: 7901192
[TBL] [Abstract][Full Text] [Related]
3. Parametric polar maps of regional myocardial beta-adrenoceptor density.
de Jong RM; Rhodes CG; Anthonio RL; Willemsen AT; Blanksma PK; Lammertsma AA; Rosen SD; Vaalburg W; Crijns HJ; Camici PG
J Nucl Med; 1999 Apr; 40(4):507-12. PubMed ID: 10210207
[TBL] [Abstract][Full Text] [Related]
4. Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography.
Qing F; Hayes MJ; Rhodes CG; Krausz T; Fountain SW; Burke MM; Jones T; Hughes JM
Thorax; 1996 Jul; 51(7):727-32. PubMed ID: 8882081
[TBL] [Abstract][Full Text] [Related]
5. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method.
Delforge J; Syrota A; Lançon JP; Nakajima K; Loc'h C; Janier M; Vallois JM; Cayla J; Crouzel C
J Nucl Med; 1991 Apr; 32(4):739-48. PubMed ID: 1672889
[TBL] [Abstract][Full Text] [Related]
6. Specific beta-adrenergic receptor binding of carazolol measured with PET.
Berridge MS; Nelson AD; Zheng L; Leisure GP; Miraldi F
J Nucl Med; 1994 Oct; 35(10):1665-76. PubMed ID: 7931670
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy.
Merlet P; Delforge J; Syrota A; Angevin E; Mazière B; Crouzel C; Valette H; Loisance D; Castaigne A; Randé JL
Circulation; 1993 Apr; 87(4):1169-78. PubMed ID: 8096441
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors.
Qing F; Rahman SU; Hayes MJ; Rhodes CG; Ind PW; Jones T; Hughes JM
J Nucl Cardiol; 1997; 4(6):532-8. PubMed ID: 9456194
[TBL] [Abstract][Full Text] [Related]
9. In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density.
Delforge J; Mesangeau D; Dolle F; Merlet P; Loc'h C; Bottlaender M; Trebossen R; Syrota A
J Nucl Med; 2002 Feb; 43(2):215-26. PubMed ID: 11850488
[TBL] [Abstract][Full Text] [Related]
10. In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy.
Hayes MJ; Qing F; Rhodes CG; Rahman SU; Ind PW; Sriskandan S; Jones T; Hughes JM
Am J Respir Crit Care Med; 1996 Nov; 154(5):1277-83. PubMed ID: 8912736
[TBL] [Abstract][Full Text] [Related]
11. Measurement of myocardial beta-adrenoceptor density in clinical studies: a role for positron emission tomography?
de Jong RM; Blanksma PK; van Waarde A; van Veldhuisen DJ
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):88-97. PubMed ID: 11807612
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.
Law MP
Br J Pharmacol; 1993 Aug; 109(4):1101-9. PubMed ID: 8104642
[TBL] [Abstract][Full Text] [Related]
13. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
14. Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic model.
Doze P; Elsinga PH; van Waarde A; Pieterman RM; Pruim J; Vaalburg W; Willemsen AT
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):295-304. PubMed ID: 12002702
[TBL] [Abstract][Full Text] [Related]
15. Development of radioligands for the imaging of cardiac beta-adrenoceptors using SPECT. Part II: Pharmacological characterization in vitro and in vivo of new 123I-labeled beta-adrenoceptor antagonists.
Dubois EA; Somsen GA; van den Bos JC; Janssen AG; Batink HD; Boer GJ; van Royen EA; Pfaffendorf M; van Zwieten PA
Nucl Med Biol; 1997 Jan; 24(1):9-13. PubMed ID: 9080469
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pulmonary and myocardial beta-adrenoceptors with S-1'-[fluorine-18]fluorocarazolol.
Visser TJ; van Waarde A; van der Mark TW; Kraan J; Elsinga PH; Pruim J; Ensing K; Jansen T; Willemsen AT; Franssen EJ; Visser GM; Paans AM; Vaalburg W
J Nucl Med; 1997 Feb; 38(2):169-74. PubMed ID: 9025729
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
Riva MA; Creese I
Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of (S)-4-(3-(2'-[11C]isopropylamino)-2-hydroxypropoxy) -2H-benzimidazol -2-one ((S)-[11C]CGP 12388) and (S)-4-(3-((1'-[18F]-fluoroisopropyl)amino)-2-hydroxypropoxy) -2H- benzimidazol-2-one ((S)-[18F]fluoro-CGP 12388) for visualization of beta-adrenoceptors with positron emission tomography.
Elsinga PH; van Waarde A; Jaeggi KA; Schreiber G; Heldoorn M; Vaalburg W
J Med Chem; 1997 Nov; 40(23):3829-35. PubMed ID: 9371248
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.
Doze P; Elsinga PH; Maas B; Van Waarde A; Wegman T; Vaalburg W
Neurochem Int; 2002 Feb; 40(2):145-55. PubMed ID: 11738481
[TBL] [Abstract][Full Text] [Related]
20. Correction of a relationship that assesses beta-adrenergic receptor concentration with PET and carbon-11-CGP 12177.
Delforge J
J Nucl Med; 1994 May; 35(5):921. PubMed ID: 7909842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
